Literature DB >> 15499162

The truth about silver.

Liza G Ovington1.   

Abstract

Interest in silver as a topical agent in wound healing is undergoing a renaissance. Having basic information regarding silver's chemical properties and potential actions in the wound bed is important to its appropriate clinical use. Such information is also relevant to the interpretation of silver's in vitro antimicrobial (antiseptic) effects, which in turn relate to issues involved in the evaluation of the clinical effects of silver in vivo. Gaining an understanding of the basic science of silver products and the different challenges inherent to in vitro versus in vivo antimicrobial evaluations will allow clinicians to address several key questions inherent when considering the use of silver as a topical antimicrobial: 1) Are there different forms of silver? 2) How does the amount of silver released into the wound environment correlate with clinical benefit? 3) How does the rate of silver release correlate with clinical benefit?

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499162

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  21 in total

Review 1.  Silver dressings: their role in wound management.

Authors:  David J Leaper
Journal:  Int Wound J       Date:  2006-12       Impact factor: 3.315

Review 2.  A clinical review of infected wound treatment with Vacuum Assisted Closure (V.A.C.) therapy: experience and case series.

Authors:  Allen Gabriel; Jaimie Shores; Brent Bernstein; Jean de Leon; Ravi Kamepalli; Tom Wolvos; Mona M Baharestani; Subhas Gupta
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

Review 3.  Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications.

Authors:  Bogumiła Reidy; Andrea Haase; Andreas Luch; Kenneth A Dawson; Iseult Lynch
Journal:  Materials (Basel)       Date:  2013-06-05       Impact factor: 3.623

4.  The use of BMP-2 coupled - Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects.

Authors:  Zhong Zheng; Wei Yin; Janette N Zara; Weiming Li; Jinny Kwak; Rachna Mamidi; Min Lee; Ronald K Siu; Richard Ngo; Joyce Wang; Doug Carpenter; Xinli Zhang; Benjamin Wu; Kang Ting; Chia Soo
Journal:  Biomaterials       Date:  2010-09-22       Impact factor: 12.479

5.  Prospective, Descriptive Study of Critically Colonized Venous Leg Ulcers Managed With Silver Containing Absorbent Dressings and Compression.

Authors:  Michael F Moore
Journal:  J Am Coll Clin Wound Spec       Date:  2014-09-16

6.  The effect of a silver-containing Hydrofiber dressing on superficial wound bed and bacterial balance of chronic wounds.

Authors:  Pat Coutts; R Gary Sibbald
Journal:  Int Wound J       Date:  2005-12       Impact factor: 3.315

7.  Dual Functional Lysozyme-Chitosan Conjugate for Tunable Degradation and Antibacterial Activity.

Authors:  Soyon Kim; Jiabing Fan; Chung-Sung Lee; Min Lee
Journal:  ACS Appl Bio Mater       Date:  2020-03-08

8.  Negative pressure wound therapy with instillation: a pilot study describing a new method for treating infected wounds.

Authors:  Allen Gabriel; Jaimie Shores; Cherrie Heinrich; Waheed Baqai; Sharon Kalina; Norman Sogioka; Subhas Gupta
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

9.  Silver-doped bioactive glass particles for in vivo bone tissue regeneration and enhanced methicillin-resistant Staphylococcus aureus (MRSA) inhibition.

Authors:  Natalia Pajares-Chamorro; Yadav Wagley; Chima V Maduka; Daniel W Youngstrom; Alyssa Yeger; Stephen F Badylak; Neal D Hammer; Kurt Hankenson; Xanthippi Chatzistavrou
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-11-05       Impact factor: 7.328

10.  Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial.

Authors:  Alireza Khatami; Rezvan Talaee; Makan Rahshenas; Ali Khamesipour; Pedram Mehryan; Sepideh Tehrani; Yahya Dowlati; Alireza Firooz
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.